Conclusions
thrombosis, bleeding, death
THROMBOSIS, BLEEDING
For patients at high risk for bleeding, a strategy of PCI with biodegradable-polymer sirolimus-eluting stents followed by 30 days of DAPT was noninferior to durable-polymer zotarolimus-eluting stents with respect to the incidence of death from cardiac causes, MI, or stent thrombosis.